Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

The Trump administration on Wednesday pursued new efforts in a sweeping initiative to root out fraud in federal health ...

Alison is a senior news reporter covering US politics and legal news. President-elect Donald Trump tapped Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services (CMS) on Wednesday, ...

Dr. Mehmet Oz built his reputation as “America’s Doctor” by dispensing easy-to-follow medical advice on TV. Now he’s going ...

The Centers for Medicare & Medicaid Services will have to audit states “more aggressively” if they don't take the request seriously, Administrator Mehmet Oz said. Centers for Medicare & Medicaid ...

Have a question for Jessica Rendall or our other editors? Ask here for a chance to be featured in a story. Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

A KFF survey finds that states want more guidance on implementing new Medicaid work requirements from Centers for Medicare ...

Hospitals face rising Medicaid cuts and financial strain as leaders warn we cannot cut our way to success amid pending HR 1 changes.

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month.

There is no governmental mechanism to pay for an AI agent that monitors a patient between visits, calls to check in, ...